Display options
Cite
Mattoscio D, Casadio C, Fumagalli M, et al. The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections. Ecancermedicalscience. 2015;9:534doi: 10.3332/ecancer.2015.534.
Mattoscio, D., Casadio, C., Fumagalli, M., Sideri, M., & Chiocca, S. (2015). The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections. Ecancermedicalscience, 9534. https://doi.org/10.3332/ecancer.2015.534
Mattoscio, Domenico, et al. "The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections." Ecancermedicalscience vol. 9 (2015): 534. doi: https://doi.org/10.3332/ecancer.2015.534
Mattoscio D, Casadio C, Fumagalli M, Sideri M, Chiocca S. The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections. Ecancermedicalscience. 2015 Apr 29;9:534. doi: 10.3332/ecancer.2015.534. eCollection 2015. PMID: 26015803; PMCID: PMC4435752.
Copy Download .nbib Format: NLM
Share it on

Ecancermedicalscience. 2015 Apr 29;9:534. doi: 10.3332/ecancer.2015.534. eCollection 2015.

The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections.

Ecancermedicalscience

Domenico Mattoscio, Chiara Casadio, Marzia Fumagalli, Mario Sideri, Susanna Chiocca

Affiliations

  1. European Institute of Oncology, Department of Experimental Oncology, Via Adamello 16, 20139 Milan, Italy ; Equally contributed to this work.
  2. European Institute of Oncology, Department of Pathology, 20141 Milan, Italy ; Equally contributed to this work.
  3. TTFactor Srl, Via Adamello 16, 20139 Milan, Italy.
  4. European Institute of Oncology, Division of Gynecology, 20141 Milan, Italy.
  5. European Institute of Oncology, Department of Experimental Oncology, Via Adamello 16, 20139 Milan, Italy.

PMID: 26015803 PMCID: PMC4435752 DOI: 10.3332/ecancer.2015.534

Abstract

Human papillomaviruses (HPVs) infect stratified epithelium and are the causative agents of cervical cancer, the second most common cause of cancer-related death in women. A critical aspect that still persists in the HPV field is the selection of very sensitive and specific HPV diagnostic assays. Here, we provide evidence that the crucial small ubiquitin-like modifier (SUMO) E2-conjugating enzyme Ubc9 is strongly upregulated in cervical lesions. Ubc9 detection could thus be used in diagnosing and/or monitoring the progression of an HPV oncogenic infection.

Keywords: HPV; HSIL; LSIL; SUMO; Ubc9; biomarker; cervical cancer

References

  1. Clin Cancer Res. 2009 Mar 1;15(5):1550-7 - PubMed
  2. Nat Rev Mol Cell Biol. 2007 Dec;8(12):947-56 - PubMed
  3. Nat Rev Microbiol. 2013 Jun;11(6):400-11 - PubMed
  4. Hepatology. 2012 Sep;56(3):982-93 - PubMed
  5. Pathol Res Pract. 2014 Jan;210(1):10-7 - PubMed
  6. Lancet Oncol. 2013 Feb;14(2):168-76 - PubMed
  7. Nat Rev Cancer. 2010 Aug;10(8):550-60 - PubMed
  8. Am J Clin Pathol. 2010 Jul;134(1):12-21 - PubMed
  9. Mol Cell. 2005 Apr 1;18(1):1-12 - PubMed
  10. BMB Rep. 2012 Nov;45(11):641-6 - PubMed
  11. Oncogene. 2013 May 9;32(19):2493-8 - PubMed
  12. Chin J Cancer. 2011 Sep;30(9):638-44 - PubMed
  13. IUBMB Life. 2014 Jan;66(1):27-33 - PubMed
  14. Carcinogenesis. 2014 Aug;35(8):1830-9 - PubMed
  15. Oncogene. 2010 Mar 25;29(12 ):1763-72 - PubMed
  16. Med Oncol. 2014 Jan;31(1):767 - PubMed
  17. Virus Res. 2011 Jun;158(1-2):199-208 - PubMed
  18. Oncogene. 2005 Apr 14;24(16):2677-83 - PubMed
  19. Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18168-73 - PubMed
  20. Lancet Oncol. 2008 Oct;9(10):937-45 - PubMed
  21. Curr Opin Microbiol. 2006 Aug;9(4):430-6 - PubMed
  22. Cell Cycle. 2005 Apr;4(4):533-5 - PubMed
  23. Neoplasia. 2002 Mar-Apr;4(2):141-50 - PubMed
  24. World J Virol. 2013 May 12;2(2):79-90 - PubMed
  25. Front Biosci (Schol Ed). 2013 Jan 01;5:544-53 - PubMed
  26. Pharmacogenomics J. 2010 Apr;10 (2):86-93 - PubMed
  27. J Biol Chem. 2007 May 25;282(21):15376-82 - PubMed
  28. Semin Cancer Biol. 2014 Jun;26:13-21 - PubMed
  29. Blood. 2007 Nov 1;110(9):3301-9 - PubMed
  30. Curr Biol. 2002 Apr 2;12(7):594-8 - PubMed
  31. Oncol Rep. 2013 Apr;29(4):1588-94 - PubMed
  32. Int J Biochem Cell Biol. 2015 Jan;58:28-36 - PubMed
  33. EMBO Rep. 2002 Nov;3(11):1062-8 - PubMed
  34. Obstet Gynecol. 2003 Dec;102(6):1269-77 - PubMed
  35. J Natl Cancer Inst. 2011 Mar 2;103(5):368-83 - PubMed
  36. Head Neck. 2009 Jul;31(7):845-55 - PubMed
  37. Oncogene. 2007 Jun 21;26(29):4216-25 - PubMed
  38. Mol Cell. 2004 Nov 19;16(4):549-61 - PubMed
  39. Cancer Treat Rev. 2009 May;35(3):210-20 - PubMed

Publication Types